150 related articles for article (PubMed ID: 11410024)
21. Predictive QSAR modeling of CCR5 antagonist piperidine derivatives using chemometric tools.
Roy K; Mandal AS
J Enzyme Inhib Med Chem; 2009 Feb; 24(1):205-23. PubMed ID: 18608745
[TBL] [Abstract][Full Text] [Related]
22. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
Ahmadi S; Habibpour E
Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
[TBL] [Abstract][Full Text] [Related]
23. Reduced density gradient as a novel approach for estimating QSAR descriptors, and its application to 1, 4-dihydropyridine derivatives with potential antihypertensive effects.
Jardínez C; Vela A; Cruz-Borbolla J; Alvarez-Mendez RJ; Alvarado-Rodríguez JG
J Mol Model; 2016 Dec; 22(12):296. PubMed ID: 27889884
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, Docking Simulation, Biological Evaluations and 3D-QSAR Study of 1,4-Dihydropyridines as Calcium Channel Blockers.
El-Moselhy TF; Sidhom PA; Esmat EA; El-Mahdy NA
Chem Pharm Bull (Tokyo); 2017; 65(10):893-903. PubMed ID: 28966273
[TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of new 1,4-dihydropyridines containing 4(5)-chloro-5(4)-imidazolyl substituent as a novel calcium channel blocker.
Iman M; Davood A; Nematollahi AR; Dehpoor AR; Shafiee A
Arch Pharm Res; 2011 Sep; 34(9):1417-26. PubMed ID: 21975802
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
Ventura C; Latino DA; Martins F
Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731
[TBL] [Abstract][Full Text] [Related]
27. A self-adaptive genetic algorithm-artificial neural network algorithm with leave-one-out cross validation for descriptor selection in QSAR study.
Wu J; Mei J; Wen S; Liao S; Chen J; Shen Y
J Comput Chem; 2010 Jul; 31(10):1956-68. PubMed ID: 20512843
[TBL] [Abstract][Full Text] [Related]
28. [Quantitative structure-activity relationship model for prediction of cardiotoxicity of chemical components in traditional Chinese medicines].
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 49(3):551-556. PubMed ID: 28628163
[TBL] [Abstract][Full Text] [Related]
29. Deriving a quantitative chirality measure from molecular similarity indices.
Benigni R; Cotta-Ramusino M; Gallo G; Giorgi F; Giuliani A; Varì MR
J Med Chem; 2000 Oct; 43(20):3699-703. PubMed ID: 11020284
[TBL] [Abstract][Full Text] [Related]
30. Integrated analysis on the physicochemical properties of dihydropyridine calcium channel blockers in grapefruit juice interactions.
Uesawa Y; Takeuchi T; Mohri K
Curr Pharm Biotechnol; 2012 Jul; 13(9):1705-17. PubMed ID: 22039822
[TBL] [Abstract][Full Text] [Related]
31. Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks.
Nandi S; Vracko M; Bagchi MC
Chem Biol Drug Des; 2007 Nov; 70(5):424-36. PubMed ID: 17949360
[TBL] [Abstract][Full Text] [Related]
32. Combinatorial QSAR of ambergris fragrance compounds.
Kovatcheva A; Golbraikh A; Oloff S; Xiao YD; Zheng W; Wolschann P; Buchbauer G; Tropsha A
J Chem Inf Comput Sci; 2004; 44(2):582-95. PubMed ID: 15032539
[TBL] [Abstract][Full Text] [Related]
33. Quantitative Structure-Activity Relationship Studies of 4-Imidazolyl- 1,4-dihydropyridines as Calcium Channel Blockers.
Hadizadeh F; Vahdani S; Jafarpour M
Iran J Basic Med Sci; 2013 Aug; 16(8):910-6. PubMed ID: 24106595
[TBL] [Abstract][Full Text] [Related]
34. Exploring the QSAR's predictive truthfulness of the novel N-tuple discrete derivative indices on benchmark datasets.
Martínez-Santiago O; Marrero-Ponce Y; Vivas-Reyes R; Rivera-Borroto OM; Hurtado E; Treto-Suarez MA; Ramos Y; Vergara-Murillo F; Orozco-Ugarriza ME; Martínez-López Y
SAR QSAR Environ Res; 2017 May; 28(5):367-389. PubMed ID: 28590848
[TBL] [Abstract][Full Text] [Related]
35. QSAR modeling of anti-invasive activity of organic compounds using structural descriptors.
Katritzky AR; Kuanar M; Dobchev DA; Vanhoecke BW; Karelson M; Parmar VS; Stevens CV; Bracke ME
Bioorg Med Chem; 2006 Oct; 14(20):6933-9. PubMed ID: 16908166
[TBL] [Abstract][Full Text] [Related]
36. Genesis of dihydropyrimidinone(psi) calcium channel blockers: recent progress in structure-activity relationships and other effects.
Singh K; Arora D; Singh K; Singh S
Mini Rev Med Chem; 2009 Jan; 9(1):95-106. PubMed ID: 19149663
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, study of 3D structures, and pharmacological activities of lipophilic nitroimidazolyl-1,4-dihydropyridines as calcium channel antagonist.
Miri R; Javidnia K; Sarkarzadeh H; Hemmateenejad B
Bioorg Med Chem; 2006 Jul; 14(14):4842-9. PubMed ID: 16603367
[TBL] [Abstract][Full Text] [Related]
38. Three-dimensional quantitative structure-activity relationship of 1,4-dihydropyridines as antitubercular agents.
Kharkar PS; Desai B; Gaveria H; Varu B; Loriya R; Naliapara Y; Shah A; Kulkarni VM
J Med Chem; 2002 Oct; 45(22):4858-67. PubMed ID: 12383011
[TBL] [Abstract][Full Text] [Related]
39. A comparative QSAR study using CoMFA, HQSAR, and FRED/SKEYS paradigms for estrogen receptor binding affinities of structurally diverse compounds.
Waller CL
J Chem Inf Comput Sci; 2004; 44(2):758-65. PubMed ID: 15032558
[TBL] [Abstract][Full Text] [Related]
40. Genetic neural network modeling of the selective inhibition of the intermediate-conductance Ca2+ -activated K+ channel by some triarylmethanes using topological charge indexes descriptors.
Caballero J; Garriga M; Fernández M
J Comput Aided Mol Des; 2005 Nov; 19(11):771-89. PubMed ID: 16374673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
